| アブストラクト | BACKGROUND: Cyclosporine is widely used to prevent allograft rejection after transplantation. The purpose of this study was to clarify the adverse events profiles associated with cyclosporine in transplant patients using a spontaneous reporting system database. METHODS: Retrospective pharmacovigilance disproportionality analysis was conducted using the Japanese Adverse Drug Event Report (JADER) database, with the reporting odds ratio (ROR) and 95% confidence interval (CI) for each adverse event. RESULTS: The database comprised 3,327, 958, and 956 reports associated with cyclosporine in the kidney, stem cell, and heart transplant patients, respectively. Infectious and renal disorders were commonly detected in these transplant patients. The signal scores of cyclosporine for toxic nephropathy were noteworthy in the kidney (ROR: 15.1, 95% CI: 11-20.8) and stem cell (ROR, 216; 95% CI, 29.3-1593) transplantation. Cyclosporine in heart transplantation was strongly associated with gastric cancer (ROR, 39.4; 95% CI, 16.7-93.2), but not kidney or stem cell transplantation. CONCLUSION: It was suggested that there is a diversity in the strength of the association between cyclosporine and adverse events in the kidney, stem cell, and heart transplantation. Our results may provide useful information for treatment with cyclosporine, although further research with more data is needed. |
|---|
| ジャーナル名 | Cureus |
|---|
| Pubmed追加日 | 2022/9/27 |
|---|
| 投稿者 | Niinomi, Iku; Oyama, Saki; Inada, Ayaka; Wakabayashi, Tomohito; Iida, Tatsuya; Kambara, Hiroko; Uchida, Mayako; Sano, Yukako; Hosohata, Keiko |
|---|
| 組織名 | Education and Research Center for Clinical Pharmacy, Osaka Medical and;Pharmaceutical University, Takatsuki, JPN.;Education and Research Center for Pharmacy Practice, Doshisha Women's College of;Liberal Arts, Kyotanabe-shi, JPN. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/36159360/ |
|---|
